equilliumbio.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Crawl-delay: 10 Allow: / User-agent: Eluta.ca Crawl-delay: 60 Allow: / User-agent: MS Search 6.0 Robot Crawl-delay: 60 Allow: / User-agent: gsa-crawler Crawl-delay: 60 Allow: | ||
Meta Tags
| Title | Equillium - |
| Description | Resetting Balance, Restoring Home Company About Us Executive Team Board of Directors Scientific & Clinical Advisors Partners Technology Multi-Cytokine Inhibitor Platform Itolizumab Pu |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 162.159.129.11 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
equilliumbio.com Valuation
|
US$9,938,761
Last updated: 2023-05-08 18:03:31
equilliumbio.com has Semrush global rank of 1,064,952. equilliumbio.com has an estimated worth of US$ 9,938,761, based on its estimated Ads revenue. equilliumbio.com receives approximately 1,146,781 unique visitors each day. Its web server is located in United States, with IP address 162.159.129.11. According to SiteAdvisor, equilliumbio.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$9,938,761 |
| Daily Ads Revenue | US$9,175 |
| Monthly Ads Revenue | US$275,228 |
| Yearly Ads Revenue | US$3,302,727 |
| Daily Unique Visitors | 76,453 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| equilliumbio.com. | A | 7200 | IP: 162.159.129.11 |
| equilliumbio.com. | NS | 14400 | NS Record: dns102.register.com. |
| equilliumbio.com. | NS | 14400 | NS Record: dns101.register.com. |
| equilliumbio.com. | MX | 14400 | MX Record: 10 equilliumbio-com.mail.protection.outlook.com. |
| equilliumbio.com. | TXT | 7200 | TXT Record: docusign=469fd433-d655-451e-8615-44e3acd03fb8 |
| equilliumbio.com. | TXT | 14400 | TXT Record: E9E34A97D1 |
| equilliumbio.com. | TXT | 14400 | TXT Record: v=spf1 include:spf.protection.outlook.com include:spf.emailsignatures365.com -all |
HtmlToTextCheckTime:2023-05-08 18:03:31
| Home Company About Us Executive Team Board of Directors Scientific & Clinical Advisors Partners Technology Multi-Cytokine Inhibitor Platform Itolizumab Publications Presentations Clinical Pipeline Clinical Clinical Studies EQUATOR EQUALISE Patients Patient Advocacy Our Patients Graft-Versus-Host Disease Lupus Nephritis Expanded Access Policy Investors Investor Overview Stock Information Stock Chart Analyst Coverage Press Releases Events & Presentations Email Alerts & Contacts SEC Filings Corporate Governance Governance Documents Committee Composition Investor FAQs Careers Contact Us Search query Resetting Balance, Restoring Health --> At Equillium, we leverage a deep understanding of immunology and its role in disease to pioneer new products for severe autoimmune and inflammatory disorders. --> Life is all about balance Bringing treatments designed to restore the balance of the immune system to patients who hope to restore the balance in their lives. Patient Advocacy --> When |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sat, 30 Oct 2021 11:43:06 GMT Content-Type: text/html; charset=utf-8 Connection: keep-alive Location: https://equilliumbio.com/ CF-Ray: 6a64624f9e8c632a-ORD CF-Cache-Status: HIT Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" X-Content-Type-Options: nosniff Set-Cookie: __cf_bm=nz2R1TXE6FhjSU.Lc5eYdDqA1rUlnUSG7ontTfUhL7U-1635594186-0-AQ1kC/1k4pn5/kQngty1/oCZk3noLP7Z1Qh8kdmQyaSXV8fkaIMZYY0s9pPeNGdaBwRSPXrqoOiFd6i7urIG8u0=; path=/; expires=Sat, 30-Oct-21 12:13:06 GMT; domain=.equilliumbio.com; HttpOnly; SameSite=None Server: cloudflare HTTP/2 200 date: Sat, 30 Oct 2021 11:43:06 GMT content-type: text/html; charset=utf-8 cf-ray: 6a6462502e81c54c-ORD cache-control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 last-modified: Fri, 29 Oct 2021 15:09:17 GMT strict-transport-security: max-age=3600 vary: Accept-Encoding cf-cache-status: REVALIDATED expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" x-content-type-options: nosniff x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block set-cookie: __cf_bm=UibmuDfbIvfRBAa3rRq1ktt8.6cTzlTtAN6Czz7kSio-1635594186-0-AWVQTnMts9gzNwH/7WL9qJYiGniQtkS4uyrwZzS7SXd+/7TovlUmWUXNSBi4Ou5+VwJMwI4AdQwTtIXd4RTHJUE=; path=/; expires=Sat, 30-Oct-21 12:13:06 GMT; domain=.equilliumbio.com; HttpOnly; Secure; SameSite=None server: cloudflare |
equilliumbio.com Whois Information
Domain Name: EQUILLIUMBIO.COM Registry Domain ID: 2125085743_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.register.com Registrar URL: http://www.register.com Updated Date: 2020-03-13T04:36:53Z Creation Date: 2017-05-16T22:03:06Z Registry Expiry Date: 2023-05-16T22:03:06Z Registrar: Register.com, Inc. Registrar IANA ID: 9 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS101.REGISTER.COM Name Server: DNS102.REGISTER.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T22:12:39Z <<< |